We use cookies for a better user experience. Read our Privacy Policy

I Agree

Microfluidic Device System Market

Microfluidic Device System Market - Global Industry Analysis, Trend, Size, Share and Forecast 2016 - 2024

Global Microfluidic Device System Market: Snapshot

In the last few years, the developments of microfluidic components and tools have been enthralling for the life science and pharmaceutical industries. Moreover, further developments are seen by various developing analytical applications in the several end user industries. It has been the major technology to engineer microminiaturized medical devices. Though there are various uses of this technology, but popularity of microfluidic components have increased largely in making lab-on-a-chip system. In addition, various advantages of the microfluidic components is cheap and provides swift test results that has grown its importance for making biological and chemical analyses.  Advancements made in point of care testing is likely to further expand the application of microfluidic device systems.

Other advantages of microfluidic components and tools has cheap cost of diagnostic procedures and limited use of reagents. Recently, microfluidic device system has observed numerous favorable applications in the areas of proteomics and genomics, creating many opportunities for players in the market. 

The global microfluidic device system market is expected to expand at a healthy 22.8% CAGR throughout the forecast period between 2013 and 2019. During the projected period the market to touch US$5.2 bn by 2019.

Wide Application of Microfluidic Devices System to Boost Market Growth 

The global microfluidic device system market is categorized on the basis of application, material, and industry type. The application of the microfluidic device system is seen in pharmaceuticals and life science, drug delivery, clinical and veterinary diagnostics, analytical devices, environmental and industrial, and point of care testing. Among these applications, clinical and veterinary diagnostic segment held the largest share in the market. However, it has been projected that in the coming years, the point of care testing segment could show a remarkable growth rate in the global microfluidic device system market over the forecast period.

According to the industry type, the market is segmented into pharmaceuticals, in-vitro diagnostics, and medical devices. Among these segments, the in-vitro diagnostics is the largest user of microfluidic device system and is expected to reach a valuation of US$ 3.3 bn by the end 2019. In addition, during the forecast tenure, the medical devices segment is also anticipated to increase the use of microfluidic device system that may boost the demand in the market. Based on type of material, the global market is further divided into glass, polymer, and silicon.

Low Cost Of Microfluidic Platforms In Point Of Care Testing To Rise In Developing Regions

On the regional front, the global microfluidic device system is categorized into North America, South America, Asia Pacific, Europe, and the Middle East and Africa. Out of these, North America possessed the key market share. Growing development of purpose-oriented and new microfluidic device systems are considered as the major factors for the growth the microfluidic device system market in the region.

In the meantime, the demand for medical devices is growing largely in Asia Pacific, whereas, point of care testing is the fastest growing application in the microfluidic device system market. Over the forecast period, Asia Pacific is anticipated to expand at a promising CAGR. Introduction of low-cost and portable microfluidic platforms in point of care testing in various emerging economies are supporting the growth of market in this region.

Based on the vendor landscape, the report has critically analyzed several leading players in the market. To mention a few players in the global microfluidic device system market are Abbott Laboratories, Becton Dickinson and Company, Siemens Healthcare, Agilent Technologies, Fluidigm Corporation, Roche Diagnostics, and Bio-Rad Laboratories.

Microfluidic Device System Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

 
Chapter 1 Preface 11
1.1 Report Description 11
1.2 Research Methodology 12
      1.2.1 Sources 12
              1.2.1.1 Secondary Research 12
              1.2.1.2 Primary Research 12
              1.2.1.3 Assumptions 13
 
Chapter 2 Executive Summary 14
 
Chapter 3 Industry Analysis 16
3.1 Introduction 16
3.2 Market Drivers and Opportunities 18
      3.2.1 Rising demand for point of care testing 18
      3.2.2 Miniaturization of chips, reduces cost of testing 19
      3.2.3 Increasing demand of microfluidic device in genomics and proteomics 19
      3.2.4 Change in material mix provides new opportunities for new players in the market 20
3.3 Restraints and Challenges 20
      3.3.1 Strict regulatory requirements 20
      3.3.2 Geometrical and surface chemistry issues are a challenge for microfluidics 21
 
Chapter 4 Market Trends 23
4.1 Rising number of collaborations and partnerships 23
4.2 Rising number of product innovations 24
 
Chapter 5 Porters Five Force Analysis 25
5.1 Bargaining power of buyers 25
5.2 Bargaining power of suppliers 25
5.3 Threat of new entrants 26
5.4 Threat of substitutes 26
5.5 Degree of competition 26
 
Chapter 6 Global Market Size and Forecast 27
 
Chapter 7 Segment Analysis – by Material 34
7.1 Glass 34
7.2 Polymer 36
7.3 Silicon 38
 
Chapter 8 Segment Analysis – by Industry 41
8.1 In-vitro diagnostics 41
8.2 Pharmaceuticals 43
8.3 Medical Devices 48
 
Chapter 9 Segment Analysis – by Application 52
9.1 Point of care testing 52
9.2 Pharmaceutical and life science research 54
9.3 Drug delivery 57
9.4 Analytical devices 59
9.5 Clinical and veterinary diagnostics 62
9.6 Environment and Industrial 64
 
Chapter 10 Regional Analysis 68
10.1 North America 68
10.2 Europe 70
10.3 Asia 73
10.4 Rest of the World 75
 
Chapter 11 Competitive Landscape 76
 
Chapter 12 Company Profiles 77
12.1 Roche Diagnostics 77
        12.1.1 Overview 77
        12.1.2 Products and segment 77
        12.1.3 Financial Performance 78
        12.1.4 Strategic Development 78
12.2 Abbott Laboratories 80
        12.2.1 Overview 80
        12.2.2 Products and segment 80
        12.2.3 Financial Performance 81
        12.2.4 Strategic Developments 82
12.3 Siemens Healthcare 83
        12.3.1 Overview 83
        12.3.2 Products and segment 83
        12.3.3 Financial Performance 84
        12.3.4 Strategic Development 84
12.4 Agilent Technologies Inc 85
        12.4.1 Overview 85
        12.4.2 Products and segment 85
        12.4.3 Financial Performance 86
12.5 Fluidigm Corporation 87
        12.5.1 Overview 87
        12.5.2 Products and segment 87
        12.5.3 Financial Performance 88
        12.5.4 Strategic Developments 88
12.6 Bio- Rad Laboratories 91
        12.6.1 Overview 91
        12.6.2 Products and segment 91
        12.6.3 Financial Performance 92
        12.6.4 Strategic Developments 92
12.7 Cepheid 94
        12.7.1 Overview 94
        12.7.2 Products and segment 94
        12.7.3 Financial Performance 94
        12.7.4 Strategic Developments 95
12.8 RainDance Technologies 97
        12.8.1 Overview 97
        12.8.2 Products and segment 97
        12.8.3 Financial Performance 97
        12.8.4 Strategic Development 97
12.9 Dolomite Centre 99
        12.9.1 Overview 99
        12.9.2 Products and segment 99
        12.9.3 Financial Performance 99
        12.9.4 Strategic Developments 99
12.10 Micronit Microfluidics 101
        12.10.1 Overview 101
        12.10.2 Products and segment 101
        12.10.3 Financial Performance 101
12.11 Johnson & Johnson 102
        12.11.1 Overview 102
        12.11.2 Product Segment 102
        12.11.3 Financial Performance 103
12.12 Becton, Dickinson and Company 104
        12.12.1 Overview 104
        12.12.2 Products and Segments 104
        12.12.3 Financial performance 105
        12.12.4 Strategic Developments 105
List of Tables
 
TABLE 1 Market Snapshot: microfluidic device market (2013 & 2019) 14
TABLE 2 Drivers for microfluidic devices market: Impact analysis 18
TABLE 3 Restraints for microfluidic devices market: Impact analysis 20
TABLE 4 Major collaborations and partnerships by microfluidic device companies (2011-2013) 23
TABLE 5 Some of the products launched by various companies 24
TABLE 6 Global microfluidic devices market size, by region 2009-2012 (USD million) 28
TABLE 7 Global microfluidic devices market size, by region 2013-2019 (USD million) 28
TABLE 8 Global microfluidic devices market size, by material 2009-2012 (USD million) 29
TABLE 9 Global microfluidic devices market size, by material 2013-2019 (USD million) 30
TABLE 10 Global microfluidic devices market size, by industry 2009-2012 (USD million) 31
TABLE 11 Global microfluidic devices market size, by industry 2013-2019 (USD million) 31
TABLE 12 Global microfluidic devices market size, by application 2009-2012 (USD million) 32
TABLE 13 Global microfluidic devices market size, by application 2013-2019 (USD million) 33
TABLE 14 Glass microfluidic devices market size, by region 2009-2012 (USD million) 35
TABLE 15 Glass microfluidic devices market size, by region 2013-2019 (USD million) 35
TABLE 16 Polymer microfluidic devices market size, by region 2009-2012 (USD million) 37
TABLE 17 Polymer microfluidic devices market size, by region 2013-2019 (USD million) 38
TABLE 18 Silicon microfluidic devices market size, by region 2009-2012 (USD million) 39
TABLE 19 Silicon microfluidic devices market size, by region 2013-2019 (USD million) 40
TABLE 20 In-vitro diagnostic industry in microfluidic devices market size, by region 2009-2012 (USD million) 42
TABLE 21 In-vitro diagnostic industry in microfluidic devices market size, by region 2013-2019 (USD million) 42
TABLE 22 Pharmaceutical industry in microfluidic devices market size, by region 2009-2012 (USD million) 44
TABLE 23 Pharmaceutical industry in microfluidic devices market size, by region 2013-2019 (USD million) 45
TABLE 24 Pharmaceutical industry in microfluidic devices market size, by products 2009-2012 (USD million) 46
TABLE 25 Pharmaceutical industry in microfluidic devices market size, by products 2013-2019 (USD million) 46
TABLE 26 Chips for lab analytics in microfluidic devices market size, by products 2009-2012 (USD million) 47
TABLE 27 Chips for lab analytics in microfluidic devices market size, by products 2013-2019 (USD million) 48
TABLE 28 Medical devices industry in microfluidic devices market size, by region 2009-2012 (USD million) 49
TABLE 29 Medical devices industry in microfluidic devices market size, by region 2013-2019 (USD million) 50
TABLE 30 Medical devices industry in microfluidic devices market size, by products 2009-2012 (USD million) 51
TABLE 31 Medical devices industry in microfluidic devices market size, by products 2013-2019 (USD million) 51
TABLE 32 Point of care testing in microfluidic devices market size, by region 2009-2012 (USD million) 53
TABLE 33 Point of care testing in microfluidic devices market size, by region 2013-2019 (USD million) 54
TABLE 34 Pharmaceutical and life science research in microfluidic devices market size, by region 2009-2012 (USD million) 56
TABLE 35 Pharmaceutical and life science research in microfluidic devices market size, by region 2013-2019 (USD million) 56
TABLE 36 Drug delivery in microfluidic devices market size, by region 2009-2012 (USD million) 58
TABLE 37 Drug delivery in microfluidic devices market size, by region 2013-2019 (USD million) 59
TABLE 38 Analytical devices in microfluidic devices market size, by region 2009-2012 (USD million) 61
TABLE 39 Analytical devices in microfluidic devices market size, by region 2013-2019 (USD million) 61
TABLE 40 Clinical and veterinary diagnostics in microfluidic devices market size, by region 2009-2012 (USD million) 63
TABLE 41 Clinical and veterinary diagnostics in microfluidic devices market size, by region 2013-2019 (USD million) 64
TABLE 42 Environment and industrial application in microfluidic devices market size, by region 2009-2012 (USD million) 66
TABLE 43 Environment and industrial application in microfluidic devices market size, by region 2013-2019 (USD million) 66
TABLE 44 The North American microfluidic devices market size, by country 2009-2012 (USD million) 69
TABLE 45 The North American microfluidic devices market size, by country 2013-2019 (USD million) 70
TABLE 46 The European microfluidic devices market size, by country 2009-2012 (USD million) 71
TABLE 47 The European microfluidic devices market size, by country 2013-2019 (USD million) 72
TABLE 48 The Asian microfluidic devices market size, by country 2009-2012 (USD million) 74
TABLE 49 The Asian microfluidic devices market size, by country 2013-2019 (USD million) 75
TABLE 50 Roche Diagnostics major product categories 77
TABLE 51 Abbott Laboratories major product categories 80
TABLE 52 Siemens Healthcare major product categories 83
TABLE 53 Agilent Technologies major product categories 85
TABLE 54 Major Fluidigm Corporation products and its application 87
TABLE 55 Major Bio-Rad laboratories products and categories 91
TABLE 56 Major Cepheid products and categories 94
TABLE 57 Major RainDance Technologies products and its applications 97
TABLE 58 Major Dolomite Centre products and categories 99
TABLE 59 Major Micronit Microfluidics products and categories 101
TABLE 60 Major Johnson & Johnson segments and products 102
TABLE 61 Major Becton, Dickinson and Company segments and products 104
List of Figures 
 
FIG. 1 Applications of Microfluidics 16
FIG. 2 Functions of Microfluidics 17
FIG. 3 Aging population in major regions (% 2000-2050) 18
FIG. 4 Microfluidic Device Market: Porters Five Force Analysis 25
FIG. 5 Global microfluidic device market, by region 2013 (% share) 27
FIG. 6 Global microfluidic device market, by material 2013 (% share) 29
FIG. 7 Global microfluidic device market, by industry 2013 (% share) 30
FIG. 8 Global microfluidic device market, by application 2013 (% share) 32
FIG. 9 Glass microfluidic device market, by region 2013 (% share) 34
FIG. 10 Polymer microfluidic device market, by region 2013 (% share) 36
FIG. 11 Silicon microfluidic device market, by region 2013 (% share) 39
FIG. 12 In-vitro diagnostics industry in microfluidic device market, by region 2013 (% share) 41
FIG. 13 Pharmaceutical industry in microfluidic device market, by region 2013 (% share) 43
FIG. 14 Pharmaceutical industry in microfluidic device market, by product 2013 (% share) 45
FIG. 15 Chips for lab analytics in microfluidic device market, by product 2013 (% share) 47
FIG. 16 Medical device industry in microfluidic device market, by region 2013 (% share) 49
FIG. 17 Medical devices industry in microfluidic device market, by product 2013 (% share) 50
FIG. 18 Microfluidic device material used in point of care testing in 2010 (% share) 52
FIG. 19 Point of care testing in microfluidic device market, by region 2013 (% share) 53
FIG. 20 Microfluidic device material in pharmaceutical and life science research in 2010 (% share) 55
FIG. 21 Pharmaceutical and life science research in microfluidic device market, by region 2013 (% share) 55
FIG. 22 Microfluidic device material in drug delivery in 2010 (% share) 57
FIG. 23 Drug delivery in microfluidic device market, by region 2013 (% share) 58
FIG. 24 Microfluidic device material in analytical devices in 2010 (% share) 60
FIG. 25 Analytical Devices in microfluidic device market, by region 2013 (% share) 60
FIG. 26 Microfluidic device material used in clinical and veterinary diagnosis in 2010 (% share) 62
FIG. 27 Clinical and veterinary diagnosis in microfluidic device market, by region 2013 (% share) 63
FIG. 28 Microfluidic device material in environment and industrial application in 2010 (% share) 65
FIG. 29 Environment and industrial application in microfluidic device market, by region 2013 (% share) 65
FIG. 30 The North American microfluidic device market, by country 2013 (% share) 69
FIG. 31 The European microfluidic device market, by country 2013 (% share) 71
FIG. 32 The Asian microfluidic device market, by country 2013 (% share) 74
FIG. 33 Competitive landscape of global microfluidic device market 76
FIG. 34 Roche sales and net income 2011-2013 (USD Million) 78
FIG. 35 Abbott Laboratories net sales and net earnings 2011-2013 (USD Million) 81
FIG. 36 Siemens revenue and net income 2011-2013 (USD Million) 84
FIG. 37 Agilent Technologies revenue and net income 2011-2013 (USD Million) 86
FIG. 38 Fluidigm Corporation total revenue and net income 2011-2013 (USD Million) 88
FIG. 39 Bio-Rad Laboratories net sales and net income 2010-2012 (USD Million) 92
FIG. 40 Cepheid sales and net income 2011-2013 (USD Million) 95
FIG. 41 Johnson & Johnson sales and net earnings 2011-2013 (USD Million) 103
FIG. 42 Becton, Dickinson and Company revenue and net income 2011-2013 (USD Million) 105
Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

356

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved